Sales rise 39.03% to Rs 356.47 crore
Net profit of Marksans Pharma rose 95.34% to Rs 50.73 crore in the quarter ended September 2020 as against Rs 25.97 crore during the previous quarter ended September 2019. Sales rose 39.03% to Rs 356.47 crore in the quarter ended September 2020 as against Rs 256.40 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales356.47256.40 39 OPM %23.3313.09 -PBDT84.8938.64 120 PBT65.9033.66 96 NP50.7325.97 95Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
